These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
271 related articles for article (PubMed ID: 25239875)
1. Frequency of EGFR mutations in lung adenocarcinoma with malignant pleural effusion: Implication of cancer biological behaviour regulated by EGFR mutation. Zou J; Bella AE; Chen Z; Han X; Su C; Lei Y; Luo H J Int Med Res; 2014 Oct; 42(5):1110-7. PubMed ID: 25239875 [TBL] [Abstract][Full Text] [Related]
2. EGFR mutation status in tumour-derived DNA from pleural effusion fluid is a practical basis for predicting the response to gefitinib. Kimura H; Fujiwara Y; Sone T; Kunitoh H; Tamura T; Kasahara K; Nishio K Br J Cancer; 2006 Nov; 95(10):1390-5. PubMed ID: 17060940 [TBL] [Abstract][Full Text] [Related]
3. Detection of EGFR mutation status in lung adenocarcinoma specimens with different proportions of tumor cells using two methods of differential sensitivity. Han HS; Lim SN; An JY; Lee KM; Choe KH; Lee KH; Kim ST; Son SM; Choi SY; Lee HC; Lee OJ J Thorac Oncol; 2012 Feb; 7(2):355-64. PubMed ID: 22157369 [TBL] [Abstract][Full Text] [Related]
4. EGFR-L858R mutant enhances lung adenocarcinoma cell invasive ability and promotes malignant pleural effusion formation through activation of the CXCL12-CXCR4 pathway. Tsai MF; Chang TH; Wu SG; Yang HY; Hsu YC; Yang PC; Shih JY Sci Rep; 2015 Sep; 5():13574. PubMed ID: 26338423 [TBL] [Abstract][Full Text] [Related]
5. Sea-urchin-like Au nanocluster with surface-enhanced raman scattering in detecting epidermal growth factor receptor (EGFR) mutation status of malignant pleural effusion. Wang L; Guo T; Lu Q; Yan X; Zhong D; Zhang Z; Ni Y; Han Y; Cui D; Li X; Huang L ACS Appl Mater Interfaces; 2015 Jan; 7(1):359-69. PubMed ID: 25495142 [TBL] [Abstract][Full Text] [Related]
6. Direct sequencing and amplification refractory mutation system for epidermal growth factor receptor mutations in patients with non-small cell lung cancer. Chu H; Zhong C; Xue G; Liang X; Wang J; Liu Y; Zhao S; Zhou Q; Bi J Oncol Rep; 2013 Nov; 30(5):2311-5. PubMed ID: 24002698 [TBL] [Abstract][Full Text] [Related]
7. The diagnostic accuracy of pleural effusion and plasma samples versus tumour tissue for detection of EGFR mutation in patients with advanced non-small cell lung cancer: comparison of methodologies. Liu X; Lu Y; Zhu G; Lei Y; Zheng L; Qin H; Tang C; Ellison G; McCormack R; Ji Q J Clin Pathol; 2013 Dec; 66(12):1065-9. PubMed ID: 23888061 [TBL] [Abstract][Full Text] [Related]
8. Improved detection of EGFR mutations in the tumor cells enriched from the malignant pleural effusion of non-small cell lung cancer patient. Wang Y; Liu Z; Yin H; Hu J; Zhong S; Chen W; Zhao J Gene; 2018 Feb; 644():87-92. PubMed ID: 29097164 [TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor receptor mutations in cells from non-small cell lung cancer malignant pleural effusions. Hung MS; Lin CK; Leu SW; Wu MY; Tsai YH; Yang CT Chang Gung Med J; 2006; 29(4):373-9. PubMed ID: 17051834 [TBL] [Abstract][Full Text] [Related]
10. Comparison of EGFR mutation rates in lung adenocarcinoma tissue and pleural effusion samples. Guan Y; Wang ZJ; Wang LQ; Hua DF; Liu J Genet Mol Res; 2016 Apr; 15(2):. PubMed ID: 27173189 [TBL] [Abstract][Full Text] [Related]
11. Detection of EGFR gene mutations using the wash fluid of CT-guided biopsy needle in NSCLC patients. Otani H; Toyooka S; Soh J; Yamamoto H; Suehisa H; Kobayashi N; Gobara H; Mimura H; Kiura K; Sano Y; Kanazawa S; Date H J Thorac Oncol; 2008 May; 3(5):472-6. PubMed ID: 18448998 [TBL] [Abstract][Full Text] [Related]
12. Detection of epidermal growth factor receptor mutation in non-small-cell lung carcinoma using cytological and histological specimens. Xu H; Sun W; Zhang G; Cheng Y J BUON; 2015; 20(1):142-5. PubMed ID: 25778309 [TBL] [Abstract][Full Text] [Related]
13. Analysis of intratumor heterogeneity of EGFR mutations in mixed type lung adenocarcinoma. Tomonaga N; Nakamura Y; Yamaguchi H; Ikeda T; Mizoguchi K; Motoshima K; Doi S; Nakatomi K; Iida T; Hayashi T; Nagayasu T; Tsukamoto K; Kohno S Clin Lung Cancer; 2013 Sep; 14(5):521-6. PubMed ID: 23786997 [TBL] [Abstract][Full Text] [Related]
14. RNA is favourable for analysing EGFR mutations in malignant pleural effusion of lung cancer. Tsai TH; Su KY; Wu SG; Chang YL; Luo SC; Jan IS; Yu CJ; Yu SL; Shih JY; Yang PC Eur Respir J; 2012 Mar; 39(3):677-84. PubMed ID: 21719485 [TBL] [Abstract][Full Text] [Related]
15. Detection and comparison of EGFR mutations in matched tumor tissues, cell blocks, pleural effusions, and sera from patients with NSCLC with malignant pleural effusion, by PNA clamping and direct sequencing. Yeo CD; Kim JW; Kim KH; Ha JH; Rhee CK; Kim SJ; Kim YK; Park CK; Lee SH; Park MS; Yim HW Lung Cancer; 2013 Aug; 81(2):207-12. PubMed ID: 23726527 [TBL] [Abstract][Full Text] [Related]
16. Detection and comparison of epidermal growth factor receptor mutations in cells and fluid of malignant pleural effusion in non-small cell lung cancer. Zhang X; Zhao Y; Wang M; Yap WS; Chang AY Lung Cancer; 2008 May; 60(2):175-82. PubMed ID: 18061305 [TBL] [Abstract][Full Text] [Related]
17. High expression of dihydropyrimidine dehydrogenase in lung adenocarcinoma is associated with mutations in epidermal growth factor receptor: implications for the treatment of non--small-cell lung cancer using 5-fluorouracil. Mochinaga K; Tsuchiya T; Nagasaki T; Arai J; Tominaga T; Yamasaki N; Matsumoto K; Miyazaki T; Nanashima A; Hayashi T; Tsukamoto K; Nagayasu T Clin Lung Cancer; 2014 Mar; 15(2):136-144.e4. PubMed ID: 24405586 [TBL] [Abstract][Full Text] [Related]
18. Assessment of real-time PCR method for detection of EGFR mutation using both supernatant and cell pellet of malignant pleural effusion samples from non-small-cell lung cancer patients. Shin S; Kim J; Kim Y; Cho SM; Lee KA Clin Chem Lab Med; 2017 Oct; 55(12):1962-1969. PubMed ID: 28306520 [TBL] [Abstract][Full Text] [Related]
19. Detecting EGFR mutations and ALK/ROS1 rearrangements in non-small cell lung cancer using malignant pleural effusion samples. Yao Y; Peng M; Shen Q; Hu Q; Gong H; Li Q; Zheng Z; Xu B; Li Y; Dong Y Thorac Cancer; 2019 Feb; 10(2):193-202. PubMed ID: 30565433 [TBL] [Abstract][Full Text] [Related]
20. EGFR, ERBB2, and KRAS mutations in Korean non-small cell lung cancer patients. Bae NC; Chae MH; Lee MH; Kim KM; Lee EB; Kim CH; Park TI; Han SB; Jheon S; Jung TH; Park JY Cancer Genet Cytogenet; 2007 Mar; 173(2):107-13. PubMed ID: 17321325 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]